Holen Sie sich die Stockscreener-App
0.00
100.00%
-1.40
Handel nachbörslich:
1.43
1.43
+
Tivic Health Systems Inc Aktie (TIVC) Neueste Nachrichten
Tivic Health Systems Ord Shs (VBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
VBIO|Tivic Health Systems Ord Shs|Price:0.191|Chg%:+0.020 - TradingKey
Planned cancer trial will test whether Entolimod protects marrow - Stock Titan
Daily Brief Health Care: JPJ (TCM) Limited(TCM), Abeona Therapeutics , Mani Inc, BioVie , Propanc Biopharma, Tivic Health Systems Inc and more - Smartkarma
Valion Bio, Inc.: Shareholders Board Members Managers and Company Profile | US8887053085 - marketscreener.com
Tivic Health Systems Inc. (TIVC) Holds Steady at $1.40 – Flat Trading Signals Key Decision PointVolatility Smile - dars.gov.et
Tivic Health Systems (TIVC) Holds Steady at $1.4 as Stock Consolidates Between Key LevelsVWAP Breakout - po-news-eg.net
Tivic Health Systems Inc (TIVC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tivic Health Systems Inc (TIVC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tivic Health Systems Inc (TIVC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tivic Health Systems Inc (TIVC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tivic Health Systems (TIVC) Holds Steady at $1.40 Amid Key LevelsIchimoku Kumo Break - newsline.com
House committee directs Pentagon plan for radiation drugs By Investing.com - Investing.com Australia
House committee directs Pentagon plan for radiation drugs - Investing.com UK
Congress presses for radiation drugs that work before and after exposure - Stock Titan
Tivic Health Systems (TIVC) Holds Steady at $1.40 as Traders Eye Key Support and Resistance LevelsEarly Entry Signals - po-news-eg.net
Tivic Health Systems (TIVC) Holds Steady at Key Support Level Amid Quiet TradingOverbought Signal Alerts - newsline.com
Tivic Health Systems (TIVC) Holds Steady Near Support as Traders Weigh Key LevelsEarnings Miss Risk - dars.gov.et
Tivic Health Systems Holds Steady at $1.40 – Range-Bound Action Signals Possible BreakoutSocial Sentiment - The Legal Advocate
VBIO - Finviz
Tivic Health Systems (TIVC) Holds Steady at $1.40 Amidst Sideways TradingBuffered ETF - The Legal Advocate
Tivic Health Systems (TIVC) Holds Steady at $1.40 as Key Support and Resistance Levels Define RangeRetail Volume - The Legal Advocate
Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference - The Chronicle-Journal
Tivic Health Systems, Inc.Common stock (NQ: TIVC - The Chronicle-Journal
Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform - The Malaysian Reserve
VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS - PR Newswire
Valion Bio to Report First Quarter 2026 Financial Results on May 14, 2026 - TradingView
3i group (TIVC) files amendment showing 9.99% holding and convertible exposure - Stock Titan
Valion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™ - PR Newswire
Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod - ACCESS Newswire
Valion Bio Appoints Melinda Lackey as General Counsel - The Globe and Mail
Valion Bio receives protocol for radiation syndrome drug study - Investing.com
Valion Bio receives protocol for radiation syndrome drug study By Investing.com - Investing.com Australia
Valion Bio receives first FDA-precedent study protocol from NIAID for Entolimod; federal agency to fully fund BLA-enabling in vivo program and co-navigate FDA submission - marketscreener.com
VALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSION - Barchart.com
Valion Bio (VBIO) grants 45,000 stock options to general counsel - Stock Titan
Valion Bio (VBIO) General Counsel Melinda Lackey becomes reporting insider with Form 3 - Stock Titan
Valion Bio (Nasdaq: VBIO) hires Melinda Lackey as General Counsel - Stock Titan
Tivic Health outlines $20B oncology market opportunity following strategic transformation - MSN
Tivic Health Systems, Inc. (VBIO) - Minichart
VBIO|Tivic Health Systems Ord Shs|Price:0.920|Chg%:-0.06 - TradingKey
Valion Bio (TIVC) seeks approval for equity plan, financings and 2026 board vote - Stock Titan
[ARS] Tivic Health Systems, Inc. SEC Filing - Stock Titan
Valion Bio, Inc. Common Stock (VBIO) Stock Price, News & Analysis - MarketBeat
VBIO|Tivic Health Systems Ord Shs|Price:0.880|Chg%:-0.05 - TradingKey
Price to earnings ratio of Tivic Health Systems, Inc. – NASDAQ:VBIO - TradingView
Total liabilities of Tivic Health Systems, Inc. – NASDAQ:VBIO - TradingView
Tivic Health Systems, Inc. Balance Sheet – NASDAQ:VBIO - TradingView
EBITDA margin % of Tivic Health Systems, Inc. – NASDAQ:VBIO - TradingView
Tivic Health Systems, Inc. Statistics – NASDAQ:VBIO - TradingView
CapEx per share of Tivic Health Systems, Inc. – NASDAQ:VBIO - TradingView
Tivic Health Systems, Inc. Dividends – NASDAQ:VBIO - TradingView
Tivic Health Systems, Inc. Revenue Breakdown – NASDAQ:VBIO - TradingView
Average basic shares outstanding of Tivic Health Systems, Inc. – NASDAQ:VBIO - TradingView
Total operating expenses of Tivic Health Systems, Inc. – NASDAQ:VBIO - TradingView
Operating income of Tivic Health Systems, Inc. – NASDAQ:VBIO - TradingView
Tivic Health Systems, Inc. Financial Statements – NASDAQ:VBIO - TradingView
Return on assets % of Tivic Health Systems, Inc. – NASDAQ:VBIO - TradingView
Net income of Tivic Health Systems, Inc. – NASDAQ:VBIO - TradingView
2.03%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):